Role of neutrophil-to-lymphocyte ratio as a prognostic biomarker in patients with breast cancer receiving neoadjuvant chemotherapy: a meta-analysis
Enregistré dans:
Auteurs principaux: | Jie Dong, Qiong Zhou, Qingqing Sun, Nannan Lu, Yueyin Pan, Xinghua Han |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMJ Publishing Group
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c240183e3d544c0d86de99df8b0e9aa6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
par: M. Liontos, et autres
Publié: (2021) -
Development of a predictive model utilizing the neutrophil to lymphocyte ratio to predict neoadjuvant chemotherapy efficacy in early breast cancer patients
par: Jiujun Zhu, et autres
Publié: (2021) -
Decrease in Blood Neutrophil-to-Lymphocyte Ratio Indicates Better Survival After Neoadjuvant Chemotherapy in Patients With Advanced Gastric Cancer
par: Ziyi Liu, et autres
Publié: (2021) -
The prognostic value of neutrophil-lymphocyte ratio in acute pancreatitis
par: Binit Katuwal, et autres
Publié: (2016) -
Prognostic value of the neutrophil-to-lymphocyte ratio in acute organophosphorus pesticide poisoning
par: Mu Yuhang, et autres
Publié: (2021)